Vascular consequences of menopause and hormone therapy: Importance of timing of treatment and type of estrogen

Cardiovascular Research

Volumn 66, Issue 2, 2005, Pages 295-306

  Dubey, Raghvendra K ^a,b,c   Imthurn, Bruno ^a,b   Barton, Matthias ^b   Jackson, Edwin K ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cardiovascular disease; Estrogen; Hormone therapy; Menopause

Indexed keywords

CONJUGATED ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE;

BLOOD VESSEL WALL; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFECT; ESTROGEN DEFICIENCY; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOEMBOLISM;

AGED; CARDIOVASCULAR SYSTEM; CORONARY DISEASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERTENSION; MENOPAUSE; MIDDLE AGED; OVARIECTOMY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGESTINS; RANDOMIZED CONTROLLED TRIALS; RISK;

EID: 16344390950     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.12.012     Document Type: Review

References (108)

1. C.G. Isles, D.J. Hole, V.M. Hawthorne, and A.F. Lever Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men Lancet 339 1992 702 706
2. R.E. Tracy Sex difference in coronary disease: two opposing views J Chronic Dis 19 1996 1245 1251
3. E. Barrett-Connor Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel keys lecture Circulation 95 1997 252 264
4. S.R. Maxwell Women and heart disease Basic Res Cardiol 93 Suppl-2 1998 79 84
5. E. Barrett-Connor, and T.L. Bush Estrogen and coronary heart disease in women JAMA 265 1991 1861 1867
6. W.B. Kannel, M.C. Hjortland, P.M. McNamara, and T. Gordon Menopause and risk of cardiovascular disease: the Framingham study Ann Intern Med 85 1976 447 452
7. F.B. Hu, F. Grodstein, C.H. Hennekens, G.A. Colditz, M. Johnson, and J.E. Manson Age at natural menopause and risk of cardiovascular disease Arch Intern Med 159 1999 1061 1066
8. B.K. Jacobsen, S. Nilssen, I. Heuch, and G. Kvale Does age at natural menopause affect mortality from ischemic heart disease? J Clin Epidemiol 50 1997 475 479
9. Y.T. van der Schouw, G.Y. van der Graaf, E.W. Steyerberg, J.C. Eijkemans, and J.D. Banga Age at menopause as a risk factor for cardiovascular mortality Lancet 347 1996 714 718
10. O. Joakimsen, K.H. Bonaa, E. Stensland-Bugge, and B.K. Jacobsen Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: the Tromso study J Clin Epidemiol 53 2000 525 530
11. E.G. Lakatta Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III. Cellular and molecular clues to heart and arterial aging Circulation 107 2003 490 497
12. F. Grodstein, M.J. Stampfer, J.E. Manson, G.A. Colditz, W.C. Willett, and B. Rosner Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 335 1996 453 461
13. F. Grodstein, J.E. Manson, G.A. Colditz, W.C. Willett, F.E. Speizer, and M.J. Stampfer A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease Ann Intern Med 133 2000 933 941
14. R.K. Dubey, and E.K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol, Renal Physiol 280 2001 F365 F388
15. M.E. Mendelsohn, and R.H. Karas The protective effects of estrogen on the cardiovascular system N Engl J Med 340 1999 1801 1811
16. W.J. Mack, C.C. Slater, M. Xiang, D. Shoupe, R.A. Lobo, and H.N. Hodis Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause Fertil Steril 82 2004 391 397
17. J.P. Strong, G.T. Malcom, C.A. McMahan, R.E. Tracy, W.P. Newman III, and E.E. Herderick Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the pathobiological determinants of atherosclerosis in youth study JAMA 281 1999 727 735
18. H.C. McGill Jr., and M.P. Stern Sex and atherosclerosis Atheroscler Rev 4 1979 157 242
19. C. Tejada, J.P. Strong, M.R. Montenegro, C. Restrepo, and L.A. Solberg Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex Lab Invest 18 1968 509 526
20. A.L. Dollar, A.H. Kragel, D.J. Fernicola, M.A. Waclawiw, and W.C. Roberts Composition of atherosclerotic plaques in coronary arteries in women <40 years of age with fatal coronary artery disease and implications for plaque reversibility Am J Cardiol 67 1991 1223 1227
21. K. Sutton-Tyrrell, H.C. Lassila, E. Meilahn, C. Bunker, K.A. Matthews, and L.H. Kuller Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause Stroke 29 1998 1116 1121
22. H.W. Peters, I.C.D. Westendorp, A.E. Hak, D.E. Grobbee, C.D. Stehouwer, and A. Hofman Menopausal status and risk factors for cardiovascular disease J Intern Med 246 1999 521 528
23. E. Farish, C. Fletcher, D. Hart, and M. Smith Effects of bilateral oophorectomy on lipoprotein metabolism Br J Obstet Gynaecol 97 1990 78 82
24. D.S. Celermajer, K.E. Sorensen, D.J. Spiegelhalter, D. Georgakopoulos, J. Robinson, and J.E. Deanfield Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women J Am Coll Cardiol 24 1994 471 476
25. A. Virdis, L. Ghiadoni, S. Pinto, M. Lombardo, F. Petraglia, and A. Gennazzani Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women Circulation 101 2000 2258 2263
26. K. Sudhir, M.D. Esler, G.L. Jennings, and P.A. Komesaroff Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal-women Hypertension 30 1997 1538 1543
27. F.K. Welty Preventing clinically evident coronary heart disease in the postmenopausal woman Menopause 11 2004 484 494
28. G. Mercuro, S. Zoncu, F. Saiu, M. Mascia, G.B. Melis, and G.M.C. Rosano Menopause induced by oophorectomy reveals a role of ovarian estrogen on the maintenance of pressure homeostasis Maturitas 47 2004 131 138
29. N.S. Weiss Relationship of menopause to serum cholesterol and arterial pressure: the United States health examination survey of adults Am J Epidemiol 96 1972 237 241
30. J.F. Reckelhoff, and L.A. Fortepiani Novel mechanisms responsible for postmenopausal hypertension Hypertension 43 2004 918 923
31. A. Von Eckardstein, and F.C.W. Wu Testosterone and atherosclerosis Growth Horm IGF Res 13 2003 S72 S84
32. R.K. Dubey, S. Oparil, B. Imthurn, and E.K. Jackson Sex hormones and hypertension Cardiovasc Res 53 2002 688 708
33. A. Pechère-Bertschi, and M. Burnier Female sex hormones, salt and blood pressure regulation Am J Hypertens 17 2004 994 1001
34. J.Y. Oh, E. Barrett-Connor, N.M. Wedick, and D.L. Wingard Rancho Bernardo study. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study Diabetes Care 25 2002 55 60
35. D. Grady, S.M. Rubin, D.B. Petitti, C.S. Fox, D. Black, and B. Ettinger Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 117 1992 1016 1037
36. E. Barrett-Connor, and D. Grady Hormone replacement therapy, heart disease, and other considerations Annu Rev Public Health 19 1998 55 72
37. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs Heart and Estrogen/Progestin Replacement Study (HERS) Research Group Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613
38. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 2002 321 333
39. D. Grady, D. Herrington, V. Bittner, R. Blumenthal, M. Davidson, and M. Hlatky Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS-II) JAMA 288 2002 49 57
40. E. Barrettt-Connor An epidemiologist looks at hormones and heart disease in women J Clin Endocrinol Metab 88 2003 4031 4042
41. R.K. Dubey, B. Imthurn, L.C. Zacharia, and E.K. Jackson Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from there? Hypertension 44 2004 789 795
42. N.K. Wenger, G.L. Knatterud, and P.L. Canner Early risks of hormone therapy in patients with coronary heart disease JAMA 284 2000 41 43
43. C.M. Viscoli, L.M. Brass, W.N. Kernan, P.M. Sarrel, S. Suissa, and R.I. Horwitz A clinical trial of estrogen-replacement therapy after ischemic stroke N Engl J Med 345 2001 1243 1249
44. E. Hemminki, and K. McPherson Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials BMJ 315 1997 149 153
45. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA 273 1995 199 208
46. H.N. Hodis, W.J. Mack, R.A. Lobo, D. Shoupe, A. Sevanian, and P.R. Mahrer Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial Ann Intern Med 135 2001 939 953
47. M.A. Espeland, W. Applegate, C.D. Furberg, D. Lefkowitz, L. Rice, and D. Hunninghake Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteriesnof postmenopausal women. Asymptomatic carotid atherosclerosis prevention study Am J Epidemeol 142 1995 1011 1019
48. M.J.J. DeKleijn, M.L. Bots, A.A.A. Bak, I.C. Westendorp, J. Planellas, and H.J. Coelingh Bennink Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima thickness Maturitas 32 1999 195 204
49. H.N. Hodis, W.J. Mack, S.P. Azen, R.A. Lobo, D. Shoupe, P.R. Mahrer Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women N Engl J Med 349 2003 535 545
50. S.R. Heckbert, N.S. Weiss, T.D. Koepsell, R.N. Lemaitre, N.L. Smith, and D.S. Siscovick Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women Arch Intern Med 157 1997 1330 1336
51. P. Angerer, S. Stork, W. Kothny, P. Schmitt, and C. von Schacky Effect of oral postmenopausal hormone replacement on progression of atherosclerosis. A randomised controlled trial Arterioscler Thromb Vasc Biol 21 2001 262 268
52. T.S. Mikkola, and T.B. Clarkson Estrogen replacement therapy, atherosclerosis, and vascular function Cardiovasc Res 53 2002 605 619
53. T. Mori, J. Durand, Y.-F. Chen, J.A. Thompson, S. Bakir, and S. Oparil Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery Am J Cardiol 85 2000 1276 1279
54. G. Finking, N. Krauss, S. Römer, S. Eckert, C. Lenz, and J. Kamenz β-estradiol, gender independently, reduces atheroma development but not neointimal proliferation after balloon injury in the rabbit aorta Atherosclerosis 154 2001 39 49
55. Y. Nagai, J. Metter, C.J. Earley, M.K. Kemper, L.C. Becker, and E.G. Lakatta Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia Circulation 98 1998 1504 1509
56. B.P. McGrath, Y.L. Liang, H. Teede, L.M. Shiel, J.D. Cameron, and A. Dart Age-related deterioration in arterial structure and function in postmenopausal women. Impact of hormone replacement therapy Arterioscler Thromb Vasc Biol 18 1998 1149 1156
57. G. Le Gal, V. Gourlet, P. Hogrel, G. Plu-Bureau, P.J. Touboul, and P.Y. Scarabin Hormone replacement therapy use associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study Atherosclerosis 166 2003 163 170
58. A.P. Burke, A. Farb, G. Malcom, and R. Virmani Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis Am Heart J 141 2001 S58 S62
59. O. Joakimsen, K.H. Bonaa, E. Stensland-Bugge, and B.K. Jacobsen Age and sex differences in the distribution and ultrasound morphology of carotid atherosclerosis. The Tromso-study Arterioscler Thromb Vasc Biol 19 1999 3007 3013
60. F. Grodstein, M.J. Stamfer, M. Falkeborn, T. Naessen, and I. Persson Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women Epidemeology 10 1999 476 480
61. R.K. Dubey, D.G. Gillespie, L.C. Zacharia, L.C. Zacharia, B. Imthurn, and P.J. Keller Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and MAP kinase activity Arterioscler Thromb Vasc Biol 20 2000 964 972
62. R.L. Geary, M.R. Adams, M.E. Benjamin, and J.K. Williams Conjugated equine estrogens inhibit progression of atherosclerosis but have no effect on intimal hyperplasia or arterial remodeling induced by balloon catheter injury in monkeys J Am Coll Cardiol 31 1998 1158 1164
63. M.D. Iafrati, R.H. Karas, M. Aronovitz, S. Kim, T.R. Sullivan Jr., and D.B. Lubahn Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice Nat Med 3 1997 545 548
64. R.H. Karas, J.B. Hodgin, M. Kwoun, J.H. Krege, M. Aronovitz, and W. Mackey Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice Proc Natl Acad Sci U S A 96 1999 15133 15136
65. R.L. Levine, S.J. Chen, J. Durand, Y.F. Chen, and S. Oparil Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery Circulation 94 1996 2221 2227
66. G. Pare, A. Krust, R.H. Karas, S. Dupont, M. Aronovitz, and P. Chambon Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury Circ Res 90 2002 1087 1092
67. R.K. Dubey, S.P. Tofovic, and E.K. Jackson Cardiovascular pharmacology of estradiol metabolites J Pharmacol Exp Ther 308 2004 403 409
68. L.C. Zacharia, J.A. Gogos, M. Karayiorgou, E.K. Jackson, D.G. Gillespie, and F. Barchiesi Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice Circulation 108 2003 2974 2978
69. S. Tofovic, R.K. Dubey, and E.K. Jackson 2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1-rats J Pharmacol Exp Ther 299 2001 973 977
70. K.M. Rexrode, J.E. Manson, I.-M. Lee, P.M. Ridker, P.M. Sluss, and N.R. Cook Sex hormone levels and risk of cardiovascular events in postmenopausal women Circulation 108 2003 1688 1693
71. S.M. Haffner, P.A. Newcomb, P.M. Marcus, B.E. Klein, and R. Klein Relation of sex hormones and dehydroepiandrosterone-sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women Am J Epidemiol 142 1995 925 934
72. G.B. Phillips, T.Y. Jing, and J.H. Laragh Serum sex hormone levels in post-menopausal women with hypertension J Hum Hypertens 11 1997 523 526
73. M.A. Birdsall, C.M. Farquhar, and H.D. White Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterisation Ann Intern Med 126 1997 32 35
74. G.B. Phillips, B.H. Pinkernell, and T.Y. Jing Relationship between serum sex hormones and coronary artery disease in postmenopausal women Arterioscler Thromb Vasc Biol 17 1997 695 701
75. K. Sudhir, T.M. Chou, K. Chatterjee, E.P. Smith, T.C. Williams, and J.P. Kane Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man Circulation 96 1997 3774 3777
76. A.M. Shearman, L.A. Cupples, S. Demissie, I. Peter, C.H. Schmid, and R.H. Karas Association between estrogen receptor-α gene variation and cardiovascular disease JAMA 290 2003 2263 2270
77. T. Lehtimaki, T.A. Kunnas, K.M. Mattila, M. Perola, A. Penttila, and T. Koivula Coronary artery wall atherosclerosis in relation to the estrogen receptor-1 gene polymorphism: an autopsy study J Mol Med 80 2002 176 180
78. D.M. Herrington, T.D. Howard, G.A. Hawkins, D.M. Reboussin, J. Xu, and S.L. Zheng Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease N Engl J Med 346 2002 967 974
79. H. Lu, T. Higashikata, A. Inazu, A. Nohara, W. Yu, and M. Shimizu Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia Arterioscler Thromb Vasc Biol 22 2002 817 823
80. V. Ferrero, F. Ribichini, G. Matullo, S. Guarrera, S. Carturan, and A. Vado Estrogen receptor-α polymorphisms and angiographic outcome after coronary artery stenting Arterioscler Thromb Vasc Biol 23 2003 2223 2228
81. S. Ogawa, M. Emi, M. Shiraki, T. Hosoi, Y. Ouchi, and S. Inoue Association of estrogen receptor-beta (ESR2) gene polymorphism with blood pressure J Hum Genet 45 2000 327 330
82. Y. Matsubara, M. Murata, K. Kawano, T. Zama, N. Aoki, and H. Yoshino Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels Arterioscler Thromb Vasc Biol 17 1997 3006 3012
83. W.S. Post, P.J. Goldschmidt-Clermont, C.C. Wilhide, A.W. Heldman, M.S. Sussman, and P. Ouyang Methylation of estrogen receptor gene is associated with aging and atehrosclerosis in cardiovascular system Cardiovasc Res 43 1999 985 991
84. D.M. Herrington Role of estrogen receptor-α in pharmacogenetics of estrogen action Curr Opin Lipidol 14 2003 145 150
85. D.M. Herrington, T.D. Howard, K.B. Brosnihan, D.P. McDonnell, X. Li, and G.A. Hawkins Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not c-reactive protein Circulation 105 2002 1879 1882
86. J.B. Braunstein, D.W. Kershner, P. Bray, G. Gerstenblith, S.P. Schulman, and W.S. Post Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women Chest 121 2002 906 920
87. B.M. Psaty, N.L. Smith, R.N. Lemaitre, H.L. Vos, S.R. Heckbert, and A.Z. LaCroix Hormone replacement therapy, prothrombotic mutations, and risk of incident nonfatal myocardial infarction in postmenopausal women JAMA 285 2001 906 913
88. D.M. Herrington, E. Vittinghoff, T.D. Howard, D.A. Major, J. Owen, and D.M. Reboussin Factor-V leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease Arterioscler Thromb Vasc Biol 22 2002 1012 1017
89. J.G. Liehr Genotoxicity of steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development Hum Reprod Updat 7 2001 273 281
90. O. Herkert, H. Kuhl, J. Sandow, R. Busse, and V.B. Schini-Kerth Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression. Role of the glucocorticoid receptor Circulation 104 2001 2826 2831
91. T.B. Clarkson, and S.E. Appt MPA and postmenopausal coronary artery atherosclerosis revisited Steroids 68 2003 941 951
92. Antony MS. Effects of hormone replacement therapy on atherosclerosis. thesis, Wake Forest University, Winston-Salem, NC; 2001.
93. A.A. Nabulsi, A.R. Folsom, A. White, W. Patsch, G. Heiss, and K.K. Wu Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The atherosclerosis risk in communities study investigators N Engl J Med 328 1993 1069 1075
94. G. Gardner, C.L. Banka, K.A. Roberts, A.E. Mullick, and J.C. Rutledge Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17beta-estradiol Arterioscler Thromb Vasc Biol 19 1999 854 861
95. B.A. Walsh, A.E. Mullick, R.L. Walzem, and J.C. Rutledge 17beta-estradiol reduces tumor necrosis factor-alpha-mediated LDL accumulation in the artery wall J Lipid Res 40 1999 387 396
96. P.L.J. Colvin Estrogen increases low-density lipoprotein receptor-independent catabolism of apolipoprotein B in hyperlipidemic rabbits Metabolism 45 1996 889 896
97. B.M. Wolfe, and M.W. Huff Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women J Clin Invest 83 1989 40 45
98. B.W. Walsh, H. Li, and F.M. Sacks Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism J Lipid Res 35 1994 2083 2093
99. R.A. Srivastava, N. Srivastava, M. Averna, R.C. Lin, K.S. Korach, and D.B. Lubahn Estrogen up-regulates apolipoprotein-E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway J Biol Chem 272 1997 33360 33366
100. R. Elhage, J.F. Arnal, M.T. Pieraggi, N. Duverger, C. Fiévet, and J.C. Faye 17beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 17 1997 2679 2684
101. R.A. Srivastava Estrogen-induced regulation of the ATP-binding cassette transporter-A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen Mol Cell Biochem 240 2002 67 73
102. V.I. Zannis, and J. Cohen Old and new players in the lipoprotein system Curr Opin Lipidol 11 2000 101 103
103. J.X. Rong, M. Shapiro, and E.A. Fisher Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading Proc Natl Acad Sci U S A 100 2003 13531 13536
104. T.S. Mikkola, M.S. Antony, T.B. Clarkson, and R.W. St Clair Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis Atherosclerosis 170 2003 318
105. H. Stangl, A. Graf, L. Yu, G. Cao, and K. Wyne Effect of estrogen on scavenger receptor-B1 expression in the rat J Endocrinol 175 2002 663 672
106. N. Srivastava, P.R. Chowdhury, M. Averna, and R.A. Srivastava Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein Mol Cell Biochem 220 2001 87 93
107. A. Abbas, P.J. Fadel, Z. Wang, D. Arbique, I. Jialal, and W. Vongpatanasin Contrasting effects of oral versus transdermal estrogen on serum amyloid-A (SAA) and high density lipoprotein-SAA in postmenopausal women Arterioscler Thromb Vasc Biol 24 2004 e164 e167
108. D.M. Herrington, and J.S. Parks Estrogen and HDL. All that glitters is not gold Arterioscler Thromb Vasc Biol 24 2004 1741 1742